Celexin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Celexin

Quick Facts

Property Description
Active ingredient Cephalexin
Form Capsule, tablet, oral suspension
Pharmacological class First-generation cephalosporin antibiotic
General use Eliminating susceptible bacterial infections
Origin Semi-synthetic compound

What Type of Medicine is Celexin (Cephalexin)?

Celexin is an anti-infective agent and antibiotic that contains the active ingredient Cephalexin. It belongs to the first-generation cephalosporin class of medicines, which are structurally related to penicillins but possess a distinct chemical core. As a Beta-lactam antibiotic, Cephalexin is used to eliminate various susceptible bacterial infections throughout the body, providing systemic therapy. It is classified as an essential medicine, reflecting its foundational role in standard therapeutic practice for managing common bacterial diseases.


Composition and Origin: Is Cephalexin a Synthetic Drug?

Cephalexin is a semi-synthetic compound, meaning it is chemically derived from a natural core structure, the cephalosporin nucleus, which is then chemically modified for pharmaceutical use. It is a single-ingredient product containing only Cephalexin (typically as the monohydrate) alongside necessary pharmaceutical excipients that define its physical form. This core formulation is available under multiple trade names globally, such as Keflex, Keftab, and Ceporex, each maintaining the same active ingredient and semi-synthetic origin. Cephalexin is an orally administered drug designed for convenience and systemic absorption after being taken by mouth.


Available Forms and General Function

Cephalexin is manufactured in several pharmaceutical preparations for oral administration, including a capsule, a tablet, and an oral suspension (a liquid preparation). The medicine functions through a bactericidal action, which means it actively destroys the target bacteria by preventing them from properly building their protective cell wall. By inhibiting this essential synthesis process, Cephalexin causes the pathogens to rupture and die, which is the core principle behind its general function of resolving the bacterial cause of an infection. The oral suspension form is a differentiating feature, often intended for the pediatric patient group.

Regulatory References

  1. MedlinePlus Cephalexin Information

What side effects are possible with Celexin?

Possible Side Effects and Safety Information

The safety profile for Celexin (Cephalexin) is formally documented in government regulatory materials, categorizing adverse reactions by the affected physiological system and frequency of occurrence. The majority of documented side effects involve the gastrointestinal system and skin/subcutaneous tissues.

Frequency-Classified Adverse Reactions

Side effects are classified based on regulatory frequency frameworks:

  • Common Reactions: These include gastrointestinal disturbances like diarrhoea and nausea, as well as skin reactions such as rash and pruritus (itching). Genital pruritus and vaginitis are also listed as common.
  • Uncommon Reactions: These typically involve blood and laboratory changes, such as eosinophilia and a reversible increase in liver enzymes.
  • Rare Reactions: Officially documented rare adverse events include more serious conditions like neutropenia, thrombocytopenia, reversible interstitial nephritis, and severe skin reactions.

Serious Adverse Reactions and Safety Constraints

The regulatory label highlights the potential for several rare but serious adverse reactions. These include Anaphylaxis (a severe allergic reaction), severe cutaneous adverse reactions (SCAR) like Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN). The label also addresses Clostridioides difficile-associated diarrhea (CDAD), which may occur during or after treatment cessation.

Contraindication: Cephalexin is contraindicated in patients with a known history of hypersensitivity to cephalosporin antibiotics. A critical safety consideration noted in official documents is the potential for cross-hypersensitivity with penicillins.

Population Cautions: Due to its primary excretion route, official prescribing information requires caution and potential dosage adjustment in patients with renal impairment and in older adults, where decreased renal function is more likely.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Cephalexin details the signs and required emergency actions in the event of an overdose. Immediate medical attention must be sought for all suspected overdose situations.

Overdose Scope Official Regulatory Information
Documented Presentations Overdosage commonly presents with gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain, and epigastric distress. Hematuria (blood in the urine) is also documented.
Severe Outcome Potential In cases of severe overdosage, close clinical and laboratory monitoring is mandated. This includes checks on haematological, renal, hepatic, and coagulation status until the patient is stable.
Antidote Status No specific antidote is known for Cephalexin overdosage.

Procedural Notes and Risk Factors

Management must institute general supportive measures and symptomatic treatment. The drug's official profile notes that the risk of toxic reactions may be greater in patients with impaired renal function. To reduce drug absorption, administration of activated charcoal may be considered, and consideration may be given to gastric emptying. However, the regulatory documents explicitly state that procedures such as hemodialysis, peritoneal dialysis, or forced diuresis are not established as beneficial for treating Cephalexin overdosage. The focus remains on supportive care and mandated monitoring of affected systems.

Therapeutic Uses of Celexin

Cephalexin (Celexin) is an antibiotic commonly used for managing bacterial infections by assisting in the clearance of the pathogen and addressing the associated symptom burden. This medication is relevant for infections caused by bacteria across multiple systems.


Therapeutic Support for Acute Bacterial Episodes

This medication is commonly used across conditions presenting with acute episodes of bacterial infection, including those affecting the skin and soft tissues like cellulitis and localized abscesses; those in the genitourinary system, such as urinary tract infections (UTIs); and systemic conditions like otitis media (ear infection) and certain respiratory tract infections.

Cephalexin helps address symptom clusters that may become intense or disruptive, specifically targeting the manifestations of bacterial presence, which often create noticeable physiological strain. The key therapeutic role is to assist in the clearance of the bacterial cause, which contributes to easing the overall symptom load and discomfort.

It is applied in clinical settings that involve acute or unstable symptom patterns where supportive symptom management is appropriate, reflecting its role in situations requiring short-term symptomatic assistance. This supports general well-being during symptomatic phases and helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Inflammatory Symptoms

  • The treatment assists in managing localized symptoms related to inflammatory or irritative states, such as redness, swelling, warmth, and pain, thereby providing supportive relief when these symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Celexin (Cephalexin) eligibility for use is strictly defined by regulatory criteria, primarily related to allergy status, age, and underlying health conditions.

Contraindicated Populations

Celexin is contraindicated (must not be used) in patients with a known history of hypersensitivity to cephalexin or any other cephalosporin antibiotic.

Restricted and Conditional Use

Use of Celexin requires caution in specific populations due to increased risk of complications or drug accumulation:

  • Allergy History: Caution is required for patients with a documented allergy to penicillin due to the risk of cross-hypersensitivity.
  • Renal Impairment: The medicine must be administered with caution in the presence of markedly impaired renal function, as Cephalexin is primarily excreted by the kidneys. Careful observation is needed, and dosage may require adjustment.
  • Comorbidities: Caution is advised for patients with a history of colitis, severe diarrhea, or seizures.

Age and Reproductive Status

  • Pediatric Patients: Use is generally established for children older than 1 year. Specific use in children younger than 1 year is not established under standard prescribing information.
  • Older Adults: While generally usable, caution is advised due to the higher likelihood of age-related kidney problems.
  • Pregnancy and Lactation: Available data have not established drug-associated risks during pregnancy, though caution is recommended. The drug is excreted in breast milk, and use is generally considered acceptable, but caution is also advised for nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify Cephalexin interaction patterns based on pharmacokinetic (PK) effects, pharmacodynamic (PD) effects, and constraints on administration timing. A clinically significant PK interaction involves the gout medication Probenecid, which inhibits the renal tubular secretion of Cephalexin. This results in increased and sustained plasma concentrations of the antibiotic, and co-administration is formally not recommended by regulators. Cephalexin also affects the PK of Metformin, leading to increased plasma concentrations and decreased renal clearance of Metformin itself.

Key pharmacodynamic interactions involve oral anticoagulants (e.g., Warfarin), as combination use may be associated with a prolongation of prothrombin time and an increased risk of bleeding. Additionally, there is a documented potential for increased nephrotoxicity when Cephalexin is administered with other nephrotoxic agents, including certain loop diuretics.

Cephalexin may also decrease the efficacy of estrogen-containing oral contraceptives. For mineral supplements, such as Iron or Zinc, administration must be separated from the antibiotic by at least three hours to prevent the reduction of Cephalexin bioavailability. Interactions resulting in reduced clearance or increased toxicity are of heightened concern for patients with impaired renal function.

Mechanism of Action

Cephalexin is a beta-lactam antimicrobial agent that functions as an inhibitor of bacterial cell wall synthesis. Following systemic distribution, the molecule targets the penicillin-binding proteins (PBPs), which are transpeptidases and carboxypeptidases located within the inner surface of the bacterial cell wall membrane.

Cephalexin, due to its structural resemblance to the D-Ala-D-Ala terminus of the peptidoglycan precursor, irreversibly binds to the active site of PBPs, such as PBP1A and PBP1B. This covalent interaction obstructs the transpeptidation reaction, which is the final intracellular step of peptidoglycan cross-linking required for structural integrity. The resulting defective cell wall structure cannot withstand internal osmotic pressure, leading to a cascade of autolytic enzyme activation. The system-level physiological consequence of this intracellular failure is the rapid destabilization of the cell membrane and subsequent bacterial cell lysis, resulting in microbial population reduction.

Dosage and Administration Information

Cephalexin (Celexin) is administered exclusively via the oral route, available in forms including capsules, tablets, and an oral suspension. It is stable in acid and may be taken without regard to meals, as its absorption is rapid after administration.

Standard Administration Guidelines

Feature Administration Rule
Route of Administration Oral (capsule, tablet, or liquid suspension).
Adult Dosing Schedule Total daily dosage ranges from 1 g to 4 g, administered in divided doses (e.g., 250 mg every 6 hours or 500 mg every 12 hours). The maximum daily dose is 4 g.
Treatment Duration The course typically lasts 7 to 14 days. A minimum duration of 10 days is required for infections caused by beta-haemolytic streptococci.
Liquid Suspension Use The powder for suspension must be reconstituted by adding a specified amount of water, and the final liquid must be shaken well before each measured dose.
Missed Dose A missed dose should be taken as soon as it is remembered. If it is close to the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. The dose should not be doubled.

Population-Specific Dosing

Dose adjustment is required for patients with impaired renal function. For adults with a creatinine clearance below 30 mL/min, the total dose and frequency must be reduced. For children over one year of age, the dosage is calculated based on body weight (mg/kg), typically 25 to 50 mg/kg per day in divided doses, with higher amounts for specific severe infections.

Recent Clinical Evidence

Research evidence / Overview of studies for Celexin

The evidence base for Celexin (Cephalexin) is informed by decades of clinical study focusing on its use as an antibiotic. The core evidence consists of Randomized Controlled Trials (RCTs) and various comparative studies that explore its role in managing susceptible bacterial infections, focusing on short-term outcomes related to the observed eradication of the pathogen.


Evidence for Use in Skin and Soft Tissue Infections

Cephalexin was studied for its use in infections of the skin and underlying soft tissues, such as uncomplicated cellulitis and impetigo. Researchers examined short-term RCTs and comparative trials that included adults and children with these conditions. The main outcomes measured were related to the resolution of visible infection signs (such as localized redness and swelling) and the documented microbiological eradication of susceptible bacteria.

Studies explored how signs of infection evolved in the observed populations over the defined treatment period. Findings describe patterns observed in the studies where clinical endpoints were assessed, and documented measurements of clinical success criteria and treatment failure rates when compared to other agents or an inactive control.


Evidence for Use in Urinary Tract Infections (UTIs)

Cephalexin was evaluated in comparative studies and clinical summaries for its use in managing acute Urinary Tract Infections (UTIs), which are conditions characterized by fluctuating or episodic manifestations. These studies monitored outcomes linked to inflammatory or irritative states and the microbiological eradication of the target bacteria from the urinary tract, including in both adults and children.

Findings indicate patterns related to bacteriological clearance in patients with UTIs caused by susceptible organisms. Studies explored short-course durations to measure the necessary time interval for observed responses.


Evidence Gaps and Areas of Uncertainty

Research provides context, but evidence highlights what is known—and what is still uncertain about the medicine. Comparative evidence is lacking against many of the newest antibiotic classes that have entered the market since Cephalexin’s primary evaluation. Furthermore, follow-up durations were limited in most definitive clinical trials, meaning long-term effects are not fully established concerning the durability of resolution or the stability of the condition years later. Study results reflect the specific conditions under which they were conducted, and the available research provides context but not individual predictions of outcome.

Key Studies & References

  1. Cephalexin: Drug Information

Frequently Asked Questions (FAQ)

Common questions about Celexin (FAQ)

Q: Does Celexin interact with birth control pills?

A: Official regulatory documents indicate that Cephalexin may decrease the effectiveness of birth control pills that contain estrogen. A healthcare provider can offer guidance on contraceptive options while using this medication.


Q: Is the liquid suspension form of Celexin as effective as the capsule?

A: Yes, regulatory approvals confirm that the liquid suspension form and the capsule/tablet forms are therapeutically equivalent. This means both forms are indicated and approved for treating the same specific bacterial infections.


Q: Can Cephalexin be prescribed for someone with kidney problems?

A: Official prescribing information confirms that Cephalexin can be used in the presence of impaired kidney function, but this requires caution. Due to how the body processes the medication, official guidelines note that dosage adjustments may be necessary in the presence of kidney impairment.


Q: What common infections is Celexin usually prescribed for?

A: Cephalexin is officially indicated for treating certain bacterial infections of the skin and skin structure (like cellulitis), the respiratory tract, the urinary tract (UTIs), otitis media (ear infections), and bone infections.


Q: Is Celexin safe to use during pregnancy or while breastfeeding?

A: Available data cited in regulatory documents have not established a drug-associated risk during pregnancy. The drug is excreted into breast milk, and caution is generally advised for use in nursing mothers.


Q: Can Cephalexin cause problems with your liver?

A: Official adverse reaction documents list reversible increases in liver enzymes (changes in blood tests) as uncommon or post-marketing reactions. These changes are usually transient and not indicative of severe, permanent liver problems.


Q: How long is a typical treatment course for Celexin?

A: A typical treatment duration is usually between 7 to 14 days. For specific infections, such as those caused by beta-haemolytic streptococci, a minimum duration of 10 days is officially recommended.


Q: Are there any specific foods or drinks I should avoid while on Celexin?

A: Cephalexin can be taken without regard to meals. Regulatory documents do not list prohibitions for specific foods or non-alcoholic drinks. However, official product information suggests separating the administration of mineral supplements, such as Iron and Zinc, from the antibiotic to avoid potential issues with absorption.


Q: Can Cephalexin be used to treat a tooth infection?

A: The official regulatory label does not specifically list dental or tooth infections as an approved indication. Its uses are primarily indicated for the skin, urinary tract, respiratory tract, ear, and bone infections.


Q: Can taking Celexin cause a yeast infection?

A: Yes, official safety information lists adverse reactions such as vaginitis (inflammation of the vagina) and genital pruritus (itching) as common side effects. These are recognized signs of superinfection or overgrowth by organisms like yeast, which commonly occurs with antibiotic use.


Q: Is it normal to feel tired or dizzy when taking Celexin?

A: Some authoritative patient information, such as that provided by the NIH, lists dizziness and extreme tiredness (fatigue) as reported adverse events. While these may not be the most common side effects, they are documented.


Q: How long does Celexin stay in your system after you stop taking it?

A: Cephalexin is eliminated relatively quickly. For individuals with normal kidney function, the half-life is approximately 0.6 to 1.2 hours, with over 90% of the dose typically excreted from the body within 8 hours.


Q: Does Celexin affect sleep patterns?

A: Official adverse event reports occasionally list Central Nervous System (CNS) effects like restlessness and agitation. While sleep disturbance is not a common side effect, these CNS effects could potentially interfere with normal sleep patterns.


Q: Does Celexin help with viral infections?

A: No. Cephalexin is a beta-lactam antibacterial agent. It is specifically designed to target and destroy bacteria and is not indicated for the treatment of viral infections, such as the common cold or flu.


Q: Is it okay to take pain relievers like Tylenol with Celexin?

A: Regulatory documents do not list a significant interaction between Cephalexin and acetaminophen (Tylenol, paracetamol). However, the label advises caution when combining Cephalexin with any other medication that might affect kidney function. Any potential drug interactions should be reviewed by a healthcare professional.


Q: Does Celexin have any mood-related side effects?

A: Some official resources and adverse event reports list potential psychiatric or CNS effects, which may include confusion, agitation, and hallucinations (seeing or hearing things that are not there).


Q: What kind of research supports the use of Celexin for skin infections?

A: Regulatory documents confirm the drug's use is supported by clinical trials and comparative studies. These studies examined the drug's effectiveness in achieving the resolution of visible signs of infection and the microbiological eradication of susceptible bacteria in adults and children.


Q: What is the shelf life of Celexin after the bottle is opened?

A: This information pertains to the liquid suspension form. Once the powder has been mixed with water, it is typically recommended that the liquid suspension be stored in the refrigerator and remains stable for 14 days after mixing. After this time, any remaining liquid should be discarded.


Q: Are there any long-term side effects associated with Celexin use?

A: Official regulatory documents acknowledge that follow-up durations were limited in many of the initial definitive trials. The primary safety profile focuses on short-to-medium term reactions, and long-term effects lasting years are not fully established by this data.


Q: What's the difference in strength between the different milligram options of Celexin?

A: The different strengths (e.g., 250 mg, 500 mg, 1 g) are formulated to be administered in divided doses. This flexibility supports a healthcare provider in determining the appropriate doses needed for different severities and types of infection.


Q: Why do some people experience a metallic taste when taking Celexin?

A: The chemical properties of the active ingredient, Cephalexin, often result in a bitter or unpleasant taste, which patients sometimes describe as metallic. This is a recognized characteristic of the drug formulation.


Q: Does Celexin affect blood sugar levels?

A: Regulatory documents list a drug interaction with the diabetes medication Metformin, which can increase the concentration of Metformin in the blood. There is no direct regulatory statement on Cephalexin's effect on blood glucose in individuals who do not have diabetes.


Q: Is Celexin safe for someone with a history of heart issues?

A: While there is no specific heart disease contraindication, adverse event reports occasionally list less common side effects such as chest pain and fast heartbeat (tachycardia). Any concerns regarding pre-existing heart conditions should be reviewed by a healthcare professional.


Q: Does the efficacy of Celexin decrease over time?

A: Official labeling warns that the prolonged use of Cephalexin can result in the overgrowth of nonsusceptible organisms (superinfection) and promotes the development of drug-resistant bacteria. This highlights the importance of using the medication only as directed.


Q: Does Celexin show up on drug tests?

A: Regulatory documents state that the use of Cephalosporin antibiotics, including Cephalexin, may cause a false-positive Direct Coombs Test result. This is a specific medical test used to detect certain antibodies, not a general illicit drug screening.


Q: Is Celexin considered a broad-spectrum antibiotic?

A: Cephalexin is classified as a first-generation cephalosporin antibiotic. This means it is typically effective against a useful range of Gram-positive bacteria and a more limited set of Gram-negative bacteria.

How should Celexin be stored and disposed of?

️ How to Store and Dispose of Celexin?

Cephalexin (Celexin) should be stored at room temperature, generally between 68^circF and 77^circF (20^circC and 25^circC), away from moisture and heat. Keep the medication in its original container and make sure the bottle is tightly closed.

Do not store it in the bathroom. For the liquid suspension form, check the specific labeling, as some may require refrigeration and typically remain effective for only 7 to 14 days after mixing before being discarded.

Disposal Guidelines

Disposal Method Guidance
Preferred Utilize a community drug take-back program or mail-back program when available.
Household Trash If no take-back program exists, mix the medication (do not crush tablets) with an unappealing substance, like dirt or cat litter, seal it in a plastic bag, and discard in the household trash.
Do NOT Flush Cephalexin down the toilet unless the FDA-approved labeling explicitly states it is safe to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Celexin found in:

A-Z Index: